Since 2009, MedCon has united regulators and healthcare products industry experts for unparalleled exchanges.
MedCon 2024 is hosted by AFDO/RAPS Healthcare Products Collaborative and co-sponsored by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services. The event will convene April 24-26 in Columbus for three days of purpose-driven discussions that harmonize different perspectives to inspire collaboration, lead innovation, and make a difference in patient care.
MedCon 2023 by the #s
“MedCon 2023 was full of topics and ideas relevant to our company and products. I came away with several actions to begin sharing within my company. I was able to speak with FDA attendees one-on-one to ask questions pertinent to our business.”
Quality Engineer – Regulatory, Norwood Medical
An experience like no other!
MedCon 2024 is hosted by the AFDO/RAPS Healthcare Products Collaborative and sparks open, candid conversations between global regulators and industry experts to address challenges and improve patient care.
Join us April 24-26 in Columbus to experience:
An intensive full-day preconference workshop* and our two-and-a-half-day conference
Paradigm-shifting dialogue leading to immediately transformative – and practical – solutions
Proactive and predictive methods that will protect your products, businesses, and patients
Cross-functional insights that foster critical alignment and collaboration
*Separate registration is required for the workshop.
Why attend MedCon 2024?
2024 MedCon Program Lineup
Engage and contribute in plenaries aimed at breaking barriers and solving problems, along with in-depth breakouts and the Solutions Exchange! Sessions include:
Best Practices for Engaging Patients and Using the Patient Perspective Over the Device Lifecycle
FDA’s PCCP Draft Guidance Deep Dive
International Influences on a Lifecycle Risk Management System
Regulators: Global Harmonization and Convergence Initiatives
News and Best Practices for Signals Involving Reports of Correction and Removal (806) and Adverse Events (MDRs)
Utilizing Effective Cybersecurity Risk Management as an Element of a Complete Risk Management Program
EU MDR and IVDR State of Play
Incorporating PMS Risk Assessment / HHEs Into Quality and Regulatory Systems
The Current State of Biocompatibility: Experience and Expectations
Medical Device Sterilization Sustainability: EPA’s New Rule, FDA Initiatives, and Industry’s Challenges
What You Need to Know About FDA’s Transition to Incorporate ISO 13485 by Reference Into 21 CFR 820 (QMSR)
“I can’t think of any other event where you can talk face-to-face with FDA and ask them specific questions about different laws and areas they regulate. Definitely one of the best reasons to attend MedCon!”
Director of Quality Assurance, Hardy Diagnostics
Attend MedCon 2024 and earn 12.0 RAC recertification credits.
Because of the generosity of our sponsors, we can continue our work to improve the healthcare products industry.